Gefjon Pharma is a biopharmaceutical company focused on developing innovative solutions to combat antimicrobial resistance.
Gefjon Pharma has raised $1.5M in total funding. The most recent round was Seed. The last funding was announced in March 2026.
Gefjon Pharma's investors include BioInnovation Institute Venture Lab.
Gefjon Pharma is headquartered in Frederiksberg, Denmark.
Gefjon Pharma is a biopharmaceutical company focused on developing innovative solutions to combat antimicrobial resistance.
Gefjon Pharma is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Gefjon Pharma — Funding & Investors." VCBacked, March 3, 2026, https://www.vcbacked.co/company/gefjon-pharma. Accessed August 14, 2026.
VCBacked. (2026). Gefjon Pharma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/gefjon-pharma
{{cite web |title=Gefjon Pharma — Funding & Investors |url=https://www.vcbacked.co/company/gefjon-pharma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated